Moreover, it has been shown that regulation of the RANKL/OPG ratio is one of the means by which bone resorption and formation can be maintained in equilibrium, and the RANKL/OPG ratio is indicative of osteoclastogenic activity in various bone remodeling diseases 1, 3, 52, 53. The gene discussed is TNFSF11; the disease is bone remodeling disease.